Evaluation of efficacy and safety of orlistat in obese patients

CONTEXT: Rapidly rising prevalence of obesity is alarming. Obesity predisposes to co-morbidities like hypertension, type 2 diabetes mellitus, dyslipidemias, thus substantially rising healthcare expenditure. Lifestyle modifications alone have very limited success, necessitating the addition of pharma...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Egile Nagusiak: Jain, Suyog S., Ramanand, Sunita J., Ramanand, Jaiprakash B., Akat, Pramod B., Patwardhan, Milind H., Joshi, Sachin R.
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Medknow Publications 2011
Gaiak:
Original Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC3125014/
https://ncbi.nlm.nih.gov/pubmed/21731866
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2230-8210.81938
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak